<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>155(10)</volume><submitter>Nelson KC</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>To date, no concerted effort has been made to date to evaluate the literature on number-needed-to-biopsy (NNB) metrics, particularly to account for the differences in clinician type and melanoma prevalence in certain geographic locations.&lt;h4>Objective&lt;/h4>To review and synthesize worldwide data for NNB for the diagnosis of cutaneous melanoma.&lt;h4>Data source&lt;/h4>MEDLINE, Embase, and PubMed databases were searched for English-language articles published worldwide from January 1, 2000, to November 28, 2018.&lt;h4>Study selection&lt;/h4>A total of 46 studies were included that addressed NNB for at least 3681 clinicians worldwide and included 455 496 biopsied tumors and 29 257 melanomas; primary care practitioner (PCP) data were only available from Australia.&lt;h4>Data extraction and</pubmed_abstract><journal>JAMA dermatology</journal><pagination>1167-1174</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6624799</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis.</pubmed_title><pmcid>PMC6624799</pmcid><pubmed_authors>Swetter SM</pubmed_authors><pubmed_authors>Curiel-Lewandrowski C</pubmed_authors><pubmed_authors>Nelson KC</pubmed_authors><pubmed_authors>Saboda K</pubmed_authors><pubmed_authors>Chen SC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis.</name><description>&lt;h4>Importance&lt;/h4>To date, no concerted effort has been made to date to evaluate the literature on number-needed-to-biopsy (NNB) metrics, particularly to account for the differences in clinician type and melanoma prevalence in certain geographic locations.&lt;h4>Objective&lt;/h4>To review and synthesize worldwide data for NNB for the diagnosis of cutaneous melanoma.&lt;h4>Data source&lt;/h4>MEDLINE, Embase, and PubMed databases were searched for English-language articles published worldwide from January 1, 2000, to November 28, 2018.&lt;h4>Study selection&lt;/h4>A total of 46 studies were included that addressed NNB for at least 3681 clinicians worldwide and included 455 496 biopsied tumors and 29 257 melanomas; primary care practitioner (PCP) data were only available from Australia.&lt;h4>Data extraction and</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-26T15:49:42.063Z</modification><creation>2025-04-06T14:58:05.823Z</creation></dates><accession>S-EPMC6624799</accession><cross_references><pubmed>31290958</pubmed><doi>10.1001/jamadermatol.2019.1514</doi></cross_references></HashMap>